126
Participants
Start Date
February 28, 2005
Primary Completion Date
January 31, 2006
Study Completion Date
January 31, 2006
Serostim
Serostim® 4 mg daily given for 12 weeks (following a prior 36-week treatment \[Serono Study 24380\] with Serostim® 4 mg daily given for 12 weeks, followed by 24-weeks of either Serostim® 2 mg every other day or Placebo every other day)
University of Alabama/Birmingham, Birmingham
Care Clinic, Los Angeles
Private Practice, Palm Beach
UCSD - AVRC (AntiViralResearchCenter), San Diego
Kaiser Permanente, San Francisco
Harbor-UCLA Medical Center, Torrence
AIDS Alliance, West Hollywood
Circle Medical LLC, Norwalk
Private Practice, Washington D.C.
Private Practice, Fort Lauderdale
Care Resources, Miami
Private Practice, Miami
Private Practice, North Miami Beach
Infectious Disease Associates, Sarasota
AIDS Research Consortium of Atlanta, Atlanta
Rush University Medical Center, Chicago
Community Research Initiative of New England, Boston
Tufts University School of Medicine, Boston
Hennepin County Medical Center, Minneapolis
St. Luke's Roosevelt Hospital, New York
St. Vincents Catholic Medical Center, New York
Weill Medical College of Cornell University, New York
Central Texas Clinical Research, Austin
IPD Research, Annandale
Private Practice, Spokane
St Paul Hospital, Vancouver
Lead Sponsor
EMD Serono
INDUSTRY